K. Yuen

1.1k total citations
19 papers, 621 citations indexed

About

K. Yuen is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hematology. According to data from OpenAlex, K. Yuen has authored 19 papers receiving a total of 621 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Hematology. Recurrent topics in K. Yuen's work include Blood transfusion and management (4 papers), Hematopoietic Stem Cell Transplantation (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). K. Yuen is often cited by papers focused on Blood transfusion and management (4 papers), Hematopoietic Stem Cell Transplantation (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). K. Yuen collaborates with scholars based in Australia, Malaysia and Japan. K. Yuen's co-authors include M. Wolf, Kathy McGrath, JP Matthews, J. Bishop, Jeff Szer, Alison R. Yung, Barnaby Nelson, I. A. Cooper, Rhonda Holdsworth and Margaret F. Veale and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

K. Yuen

16 papers receiving 596 citations

Peers

Countries citing papers authored by K. Yuen

Since Specialization

Citations

This map shows the geographic impact of K. Yuen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Yuen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Yuen more than expected).

Fields of papers citing papers by K. Yuen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Yuen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Yuen. The network helps show where K. Yuen may publish in the future.

Co-authorship network of co-authors of K. Yuen

This figure shows the co-authorship network connecting the top 25 collaborators of K. Yuen. A scholar is included among the top collaborators of K. Yuen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Yuen. K. Yuen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Extranasopharyngeal angiofibroma of the nasal septum 2025 ·Visual Journal of Emergency Medicine ·K. Yuen, (unknown), (unknown)	0
2	Primary laryngeal histoplasmosis: a case report 2023 ·SHILAP Revista de lepidopterología ·K. Yuen, (unknown), (unknown)	0
3	Ultra high risk (UHR) for psychosis criteria: Are there different levels of risk for transition to psychosis? 2010 ·Schizophrenia Research ·Barnaby Nelson, K. Yuen, Alison R. Yung	67
4	Stem cell factor and high-dose twice daily filgrastim is an effective strategy for peripheral blood stem cell mobilization in patients with indolent lymphoproliferative disorders previously treated with fludarabine: results of a Phase II study with an historical comparator 2008 ·Leukemia ·Kirsten Herbert, Susan Morgan, H. Miles Prince, David Westerman, M. Wolf, Dennis Carney, K. Yuen, Juliana Di Iulio, John F. Seymour	15
5	Dose escalation of radical radiation therapy in non‐small‐cell lung cancer using positron emission tomography/computed tomography‐defined target volumes: Are class solutions obsolete? 2008 ·Journal of Medical Imaging and Radiation Oncology ·Sarah Everitt, Michal Schneider, K. Yuen, (unknown), (unknown)	1
6	Phase III study of tirapazamine, cisplatin and radiation versus cisplatin and radiation for advanced squamous cell carcinoma of the head and neck 2008 ·Journal of Clinical Oncology ·Danny Rischin, L. J. Peters, Brian O’Sullivan, J. Giralt, K. Yuen, A. Trotti, J. Bernier, Jean Bourhis, Michael Henke, Richard Fisher	22
7	Primary non-Hodgkin’s lymphoma of the breast: First report of the multicentre retrospective study of the International Extranodal Lymphoma Study Group (IELSG-15) 2005 ·Journal of Clinical Oncology ·Gail Ryan, Giovanni Martinelli, K. Yuen, John F. Seymour	3
8	A prospective study to evaluate the impact of coregistered PET/CT images on radiotherapy treatment planning for esophageal cancer 2004 ·International Journal of Radiation OncologyBiologyPhysics ·Tracy L. Leong, (unknown), K. Yuen, (unknown), (unknown), (unknown), Eddie Lau, Andrew Hui, Trevor Ackerly, Samuel Y. Ngan	10
9	Comparison of neutropenia in a randomized, crossover trial of 3-, 6-, and 24-h infusions of paclitaxel 2003 ·Gynecologic Oncology ·Ross Jennens, Danny Rischin, K. Yuen, Guy C. Toner, Michael Millward	6
10	Long-term Follow-up Results of a Pilot Phase II Study of Multidrug Chemotherapy (MVP-CAB) in Patients with Advanced Urothelial Cancer 1999 ·Japanese Journal of Clinical Oncology ·Kazuo Gohji, Yūichi Ono, Atsushi Takenaka, Masashi Nomi, Masayuki Okamoto, K. Yuen, (unknown)	3
11	CLINICAL STUDY OF RADICAL RETROPUBIC PROSTATECTOMY FOR PROSTATE CANCER 1999 ·The Japanese Journal of Urology ·(unknown), Atsushi Takenaka, K. Yuen, Yumie Ono, Hidekazu Yamamoto, (unknown), Kazuo Gohji, Masayuki Okamoto	2
12	Mantle Irradiation Alone for Clinical Stage I-II Hodgkin's Disease: Long-Term Follow-Up and Analysis of Prognostic Factors in 261 Patients 1999 ·Journal of Clinical Oncology ·A. Wirth, Chao Ma, June Corry, Christine Laidlaw, K. Yuen, G.B. Ryan, (unknown), Susan R. Davis, (unknown), George Quong, K.H. Liew	17
13	Percentage increment measurements following platelet transfusions 1993 ·Transfusion Medicine ·J. Bishop, Jane Matthews, K. Yuen, Kathy McGrath, M. Wolf, Jeff Szer	1
14	The definition of refractoriness to platelet transfusions 1992 ·Transfusion Medicine ·J. Bishop, JP Matthews, K. Yuen, Kathy McGrath, M. Wolf, Jeff Szer	51
15	Factors influencing 20‐hour increments after platelet transfusion 1991 ·Transfusion ·J. Bishop, Jane Matthews, Kathy McGrath, K. Yuen, M. Wolf, Jeff Szer	87
16	A randomized trial of cisplatin versus cisplatin plus methotrexate in advanced cancer of the urothelial tract. 1989 ·Journal of Clinical Oncology ·Brian L. Hillcoat, Derek Raghavan, JP Matthews, Richard Kefford, K. Yuen, (unknown), Ian Olver, James F. Bishop, Bruce Pearson, (unknown)	73
17	Clinical factors influencing the efficacy of pooled platelet transfusions 1988 ·Blood ·(unknown), Kathy McGrath, M. Wolf, JP Matthews, (unknown), Rhonda Holdsworth, K. Yuen, Margaret F. Veale, (unknown), I. A. Cooper	163
18	Clinical factors influencing the efficacy of pooled platelet transfusions 1988 ·Blood ·(unknown), Kathy McGrath, M. Wolf, JP Matthews, (unknown), Rhonda Holdsworth, K. Yuen, Margaret F. Veale, (unknown), I. A. Cooper	12
19	Carboplatin (CBDCA, JM-8) and VP-16-213 in previously untreated patients with small-cell lung cancer. 1987 ·Journal of Clinical Oncology ·J. Bishop, Derek Raghavan, R. Stuart‐Harris, George Morstyn, R. S. Aroney, Richard Kefford, K. Yuen, (unknown), (unknown), Ian Olver	88

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact